MSB 2.16% $1.18 mesoblast limited

Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD, page-321

  1. 7,527 Posts.
    lightbulb Created with Sketch. 6789
    Nice rally. Suspect the rest of the investment world waking up to the realisation that MSB a likely shoo in for acceptance on resubmission. Still a massive binary risk with the FDA on GVHD, but if they get the nod, we all know the flood gates open on other treatments and an $800 million mkt cap will suddenly have looked all a bit silly.

    The share price finally giving some reprieve at long last, to long suffering, long term MSB holders who've invariably followed the convincing science.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.18
Change
0.025(2.16%)
Mkt cap ! $1.341B
Open High Low Value Volume
$1.15 $1.19 $1.15 $3.937M 3.357M

Buyers (Bids)

No. Vol. Price($)
16 91085 $1.18
 

Sellers (Offers)

Price($) Vol. No.
$1.18 35299 11
View Market Depth
Last trade - 14.01pm 23/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.